Searched for
DAIICHI SANKYO GROUP
NCLAT quashes Ligare Aviation's insolvency; loan from Religare Enterprises round-tripping of moneyThe National Company Law Appellate Tribunal has cancelled insolvency proceedings against Ligare Aviation. The tribunal found the National C...- Despite litigation, IHH says it is focused on key milestones for FortisMalaysia-based hospital operator IHH Healthcare has reached out to its largest shareholder Mitsui & Co. to help open communication with Jap...
- LIC trims stake in Ranbaxy to 6 per centLIC's stake in Ranbaxy has come down to 6.13 per cent from 8.15 per cent during the period from October 15, 2008 and December 20, 2013.
- Ranbaxy, Daiichi to leverage on brand strength for global marketsIn a bid to strengthen their hybrid business model, Ranbaxy and its parent firm Daiichi Sankyo will project only one of them as the face of...
- Ranbaxy, Daiichi Sankyo to collaborate in Brazil to expand businessIn Brazil, Daiichi Sankyo has built up its market presence with innovative pharmaceuticals through Daiichi Sankyo Brazil.
- Ranbaxy, Daiichi Sankyo to leverage synergies in ThailandRanbaxy Laboratories and its Japanese parent Daiichi Sankyo to integrate their business operations in Thailand to maximise synergies.
- Daiichi Sankyo reports Q3 net loss of $255 millionDaiichi Sankyo suffered a net loss of $255 million in the Octr-Dec quarter of 2011 due to a strong yen and one-time charges related to Ranb...
- Ranbaxy to sell Daiichi Sankyo product in MalaysiaDrug firm Ranbaxy Laboratories and Japan's Daiichi Sankyo today said Ranbaxy will market its parent company's products in Malaysia.
- Ranbaxy, Daiichi start joint community initiative in IndiaRanbaxy Laboratories and its parent Daiichi Sankyo today announced a joint community initiative in India with the flag-off of two mobile ru...
- Ranbaxy Laboratories to sell Daiichi Sankyo's products in ItalyRanbaxy Laboratories and its parent firm Daiichi Sankyo said they have entered into a partnership to distribute the Japanese firm's product...
- Ranbaxy, Daiichi Sankyo to expand business in MexicoThe two cos will launch Daiichi Sankyo's Olmesartan Medoxomil, used to treat high blood pressure, in Mexico before end of 2011.
- Ranbaxy transfers R&D unit to Daiichi SankyoRanbaxy Laboratories has transferred its research division for new drugs to Japan’s Daiichi Sankyo turning Ranbaxy into a pure generic drug...
- Ranbaxy transfers new drug discovery unit to Daiichi SankyoRanbaxy Laboratories on Friday said it has transferred its new drug discovery research unit (NDDR) to Daiichi Sankyo India Pharma.
- Ranbaxy launches Daiichi Sankyo's heart disease drug in IndiaRanbaxy Laboratories today launched a generic version of Prasugrel, used in treating heart diseases.
- Ranbaxy to shift focus from new drug research to genericsRanbaxy Laboratories has said it is shifting the focus of its research from the development of new drugs to that of generic drugs for effec...
- Daiichi Sankyo defers open offer to acquire Zenotech LabsDaiichi Sankyo has deferred the open offer to acquire 20% from public shareholders of Zenotech Labs as it is yet to get the approval from I...
- Daiichi sticks to open offer price for ZenotechDaiichi Sankyo, the new promoter of Ranbaxy, said it would not increase the open offer price of Rs 113.62 to buy a 20% stake in Hyderabad-b...
- Daiichi may book non-cash loss of $3.9 bn on Ranbaxy buy in Q3Japan’s Daiichi Sankyo, the new owner of India’s largest drugmaker Ranbaxy Laboratories, expects a non-cash valuation loss of $3.9 billion ...
- Daiichi sees $3.9 bn loss on Ranbaxy buyJapan's Daiichi Sankyo, the new owner of India's largest drugmaker Ranbaxy Laboratories expects a non-cash valuation loss of $3.9 billion o...
- Daiichi & Ranbaxy will rank at number 15 globally: Takashi ShodaRanbaxy Laboratories will be the Indian counterpart of Daiichi Sankyo. Whatever we do in India will be done through Ranbaxy.
Load More
